Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2025-12-25 @ 3:14 PM
NCT ID:
NCT03849768
Group ID:
EG001
Title:
Gefitinib
Description:
250mg PO once daily
Gefitinib: Drug: Gefitinib 250 mg + placebo The initial dose of Gefitinib 250 mg once daily cannot be reduced. A cycle of treatment is defined as 21 days of once daily treatment. Number of cycles: as long as patients are continuing to show clinical benefit, as judged by the Investigator, and in the absence of discontinuation criteria.
Deaths Number Affected:
69
Deaths Number At Risk:
None
Serious Number Affected:
46
Serious Number At Risk:
215
Other Number Affected:
213
Other Number At Risk:
215
Study:
NCT03849768
Results Section:
NCT03849768
Adverse Events Module:
NCT03849768